Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-02-001061
Filing Date
2002-03-28
Accepted
2002-03-28 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K j3118_10k.htm 10-K 1195525
3 EX-10.2 j3118_ex10d2.htm EX-10.2 7209
4 EX-10.19 j3118_ex10d19.htm EX-10.19 74128
5 EX-10.20 j3118_ex10d20.htm EX-10.20 33201
6 EX-10.22 j3118_ex10d22.htm EX-10.22 40171
7 EX-10.23 j3118_ex10d23.htm EX-10.23 15421
8 EX-23.1 j3118_ex23d1.htm EX-23.1 3060
  Complete submission text file 0001104659-02-001061.txt   1370846
Mailing Address 750 LEXINGTON AVE STE 1400 NEW YORK NY 10022
Business Address 750 LEXINTTON AVE STE 1400 NEW YORK NY 10022 2126884770
AXONYX INC (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25571 | Film No.: 02592305
SIC: 2834 Pharmaceutical Preparations